유착 방지제 시장 보고서 : 제품, 제제, 용도, 지역별(2024-2032년)

The global adhesion barriers market size reached US$ 1,048.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,822.1 Million by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.

An adhesion barrier refers to a liquid-, gel- or film-based medical implant that is used by surgeons to minimize the risks of postoperative adhesion formation between internal organs. It is applied to a layer of tissues before sealing them, thus preventing the formation of scar tissues (adhesion) and separating the tissues from the organs. The synthetic adhesion barriers are manufactured using hyaluronic acid, regenerated cellulose and polyethylene glycol, whereas the natural variants are made using collagen, fibrin and proteins. They are most commonly used in abdominal, orthopedic, gynecological, reconstructive, cardiovascular and urological surgeries.

Significant growth in the healthcare sector and the increasing prevalence of chronic lifestyle diseases, along with the rising geriatric population across the globe, are among the key factors driving the growth of the market. The treatment of various disorders, such as cardiovascular diseases (CVDs), obesity and gastric ailments, require numerous invasive procedures that may have a high risk of postoperative complications, thereby resulting in the increasing utilization of adhesion barriers. This, along with increasing awareness regarding the benefits of using adhesive barriers for postoperative procedures, is providing a boost to the market growth. Post-surgical adhesions are a common complication in surgeries and adhesion barriers play a crucial role in preventing adverse effects, such as impaired organ functioning, bowel obstruction, decreased fertility, difficult re-operation and extreme discomfort. Additionally, various technological advancements, such as the development of sheet- and spray-type adhesion barriers that are more effective and convenient to use during laparoscopic procedures, are acting as another growth-inducing factor. Other factors, including rising healthcare expenditures and increasing cases of sports-related injuries, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global adhesion barriers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, formulation and application.

Breakup by Product:

Synthetic

Natural

Breakup by Formulation:

Film

Liquid

Gel

Breakup by Application:

Gynecological Surgeries

General/Abdominal Surgeries

Cardiovascular Surgeries

Orthopedic Surgeries

Neurological Surgeries

Reconstructive Surgeries

Urological Surgeries

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Anika Therapeutics, Inc., Atrium Medical Corporation, Baxter International, Inc., Betatech Medical, C. R. Bard, Inc., FzioMed, Inc., LifeSciences Corporation, Medical Devices Business Services, Inc., MAST Biosurgery Inc., and Groupe Sanofi, etc.

Key Questions Answered in This Report

• 1. What was the size of the global adhesion barriers market in 2023?
• 2. What is the expected growth rate of the global adhesion barriers market during 2024-2032?
• 3. What are the key factors driving the global adhesion barriers market?
• 4. What has been the impact of COVID-19 on the global adhesion barriers market?
• 5. What is the breakup of the global adhesion barriers market based on the product?
• 6. What is the breakup of the global adhesion barriers market based on the formulation?
• 7. What is the breakup of the global adhesion barriers market based on application?
• 8. What are the key regions in the global adhesion barriers market?
• 9. Who are the key players/companies in the global adhesion barriers market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Adhesion Barriers Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Synthetic
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Natural
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Formulation

• 7.1 Film
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Liquid
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Gel
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Gynecological Surgeries
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 General/Abdominal Surgeries
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cardiovascular Surgeries
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Orthopedic Surgeries
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Neurological Surgeries
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Reconstructive Surgeries
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Urological Surgeries
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast
• 8.8 Others
  • 8.8.1 Market Trends
  • 8.8.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Anika Therapeutics Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Atrium Medical Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Baxter International, Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Betatech Medical
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 C. R. Bard, Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 FzioMed Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 LifeSciences Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Johnson & Johnson
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 MAST Biosurgery Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Groupe Sanofi
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio